ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1821

The Co-Occurrence Patterns of MRI Lesions and Incident Knee Osteoarthritis: The MOST Study

Jingbo Niu1, David T. Felson2, Tuhina Neogi3, Michael C. Nevitt4, Cora E. Lewis5, James Torner6, Ali Guermazi7, Frank Roemer8 and Yuqing Zhang3, 1Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 2Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 5Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, 6Epidemiology, University of Iowa, Iowa City, IA, 7Radiology, Boston University School of Medicine, Boston, MA, 8Klinikum Augsburg, Augsburg, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: MRI and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Imaging in Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: MRI imaging provides insights of tissue-specific lesions of osteoarthritis (OA) and has the advantage of identifying earlier pathological changes that are not evident on radiographs. While MRI lesions often co-occur, the co-occurrence patterns and their relation to the risk of incident OA have not been well evaluated. We identified distinct subgroups of knees using a latent class model according to patterns of pathological changes on MRI and examined their relation to incident radiographic knee OA (incROA).

Methods: The MOST Study recruited 3,026 subjects with or at risk for knee OA. We obtained baseline knee MRI and knee radiographs at each visit. MRIs were scored using the Whole Organ Magnetic Resonance Score (WORMS). Tibiofemoral (TF) incROA was defined by a new occurrence of KL≥2 on PA view radiograph by Month 84, and patellofemoral (PF) incROA was defined by a new occurrence of PF OA on lateral view. For specific lesions on MRI in the TF joint, i.e., cartilage morphology, meniscal tear, meniscal extrusion, bone marrow lesion, synovitis, and effusion, we used the worst WORMS score among all sub-regions to represent the severity of that lesion in the knee. We performed latent class modeling (SAS: Proc LCA) to identify subgroups of knees by patterns of MRI lesions. Each knee was assigned to a specific subgroup according to its highest membership probability. We then examined the relation of subgroups of MRI lesions to the risk of TF incROA after adjusting for age, sex, race, clinic site, history of knee injury and surgery using logistic regression model. We took the same approach to identify subgroups of MRI lesions in the PF joint and assess their relation to PF incROA.

Results: Among 579 knees without TF OA (mean age: 60.1 years, BMI 29.2 kg/m2, 59% women), we identified 4 subgroups based on baseline MRI lesions with average posterior probability 0.82: mostly normal (Group 1, 48.0%); predominantly cartilage lesion (Group 2, 24.9%); predominantly meniscal lesions (Group 3, 13.8%); and combined cartilage and meniscal lesions (Group 4, 13.3%) (Table). In Group 3, meniscal tear was more prevalent than meniscal extrusion. Bone marrow lesion, synovitis, and effusion were common in Groups 2 and 4. The risk of TF incROA was 12.2%, 22.9%, 31.3% and 44.2%, for Group 1, 2, 3 and 4, respectively. The corresponding odds ratios (ORs) of TF incROA and 95% CI were 1.0, 2.5 (1.4, 4.4), 5.4 (2.8, 10.5), and 8.2 (4.3, 15.7). Similarly, 4 subgroups of MRI lesions were identified in PF joints among 660 knees without PF OA. The ORs of PF incROA for each subgroup were 1.0, 4.3, 8.9, and 17.0, respectively.

Conclusion: The latent class analysis allowed insights of the patterns of MRI lesions. Among the four subgroups of MRI lesions we identified, the co-occurrence of cartilage and meniscal lesion markedly increased the risk of incident ROA, and the meniscal lesion subgroup posed a higher risk than the cartilage lesion subgroup.

Table. Baseline MRI lesions in the subgroups identified by latent class analysis

Group1

Group 2

Group 3

Group 4

TF joint

Mostly normal

Predominantly cartilage lesion

Predominantly meniscal lesions

Combined cartilage and meniscal lesions

N of knees

278

144

80

77

%TF cartilage morphology,

0 (no lesion)

62.2

0.0

37.5

0.0

 2 (mild lesion)

13.7

24.3

30.0

7.8

 3-4 (moderate lesion)

14.4

47.2

32.5

46.8

2.5/5-6 (lesion extending to bone)

9.7

28.5

0.0

45.5

%Meniscal tear, 

1+(any lesion)

0.0

20.8

100.0

58.4

%Meniscal extrusion,

1+(any lesion)

19.8

0.0

45.0

96.1

%TF bone marrow lesion

1+(any lesion)

18.0

65.3

31.3

68.8

%Synovitis,  

1+(any lesion)

36.3

86.8

47.5

76.6

%Effusion,   

1+(any lesion)

29.1

83.3

43.8

83.1

PF joint     

Mostly normal

Combined mild/ moderate cartilage and meniscal lesions

Predominantly meniscal lesions

Combined moderate/ severe cartilage and meniscal lesions

N of knees

203

121

94

242

%PF cartilage morphology,

0 (no lesion)

75.9

0.8

38.3

0.4

 2 (mild lesion)

4.4

55.4

13.8

0.0

 3-4 (moderate lesion)

19.7

43.8

39.4

41.3

2.5/5-6 (lesion extending to bone)

0.0

0.0

8.5

58.3

%Meniscal tear, 

1+(any lesion)

14.8

48.8

94.7

17.4

%Meniscal extrusion,

1+(any lesion)

19.7

22.3

89.4

30.2

%PF bone marrow lesion

1+(any lesion)

6.9

61.2

19.1

91.7

%Synovitis,  

1+(any lesion)

36.9

62.8

66.0

68.2

%Effusion,   

1+(any lesion)

24.1

55.4

77.7

69.4


Disclosure:

J. Niu,
None;

D. T. Felson,
None;

T. Neogi,
None;

M. C. Nevitt,
None;

C. E. Lewis,
None;

J. Torner,
None;

A. Guermazi,
None;

F. Roemer,
None;

Y. Zhang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-co-occurrence-patterns-of-mri-lesions-and-incident-knee-osteoarthritis-the-most-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology